189 related articles for article (PubMed ID: 3581062)
21. Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy.
Chen Q; Huang Z; Chen H; Shapiro H; Beckers J; Hetzel FW
Photochem Photobiol; 2002 Aug; 76(2):197-203. PubMed ID: 12194217
[TBL] [Abstract][Full Text] [Related]
22. Isolation and initial characterization of mouse tumor cells resistant to porphyrin-mediated photodynamic therapy.
Luna MC; Gomer CJ
Cancer Res; 1991 Aug; 51(16):4243-9. PubMed ID: 1831066
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins.
Gomer CJ; Ryter SW; Ferrario A; Rucker N; Wong S; Fisher AM
Cancer Res; 1996 May; 56(10):2355-60. PubMed ID: 8625311
[TBL] [Abstract][Full Text] [Related]
24. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
[TBL] [Abstract][Full Text] [Related]
25. Cross-resistance to photofrin-mediated photodynamic therapy and UV light and recovery from photodynamic therapy damage in Rif-8A mouse fibrosarcoma cells measured using viral capacity.
DiProspero L; Singh G; Wilson BC; Rainbow AJ
J Photochem Photobiol B; 1997 Apr; 38(2-3):143-51. PubMed ID: 9203375
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy of oncogene-transformed cells.
Pass HI; Evans S; Matthews WA; Perry R; Venzon D; Roth JA; Smith P
J Thorac Cardiovasc Surg; 1991 May; 101(5):795-9. PubMed ID: 1827169
[TBL] [Abstract][Full Text] [Related]
28. Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.
Anderson C; Hrabovsky S; McKinley Y; Tubesing K; Tang HP; Dunbar R; Mukhtar H; Elmets CA
Photochem Photobiol; 1997 May; 65(5):895-901. PubMed ID: 9155263
[TBL] [Abstract][Full Text] [Related]
29. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
Chen B; Roskams T; de Witte PA
Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
[TBL] [Abstract][Full Text] [Related]
30. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy.
Cecic I; Stott B; Korbelik M
Int Immunopharmacol; 2006 Aug; 6(8):1259-66. PubMed ID: 16782538
[TBL] [Abstract][Full Text] [Related]
31. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
[TBL] [Abstract][Full Text] [Related]
32. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model.
Chen B; Xu Y; Roskams T; Delaey E; Agostinis P; Vandenheede JR; de Witte P
Int J Cancer; 2001 Jul; 93(2):275-82. PubMed ID: 11410877
[TBL] [Abstract][Full Text] [Related]
34. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.
Sitnik TM; Hampton JA; Henderson BW
Br J Cancer; 1998 May; 77(9):1386-94. PubMed ID: 9652753
[TBL] [Abstract][Full Text] [Related]
35. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
[TBL] [Abstract][Full Text] [Related]
36. The role of strong hypoxia in tumors after treatment in the outcome of bacteriochlorin-based photodynamic therapy.
Krzykawska-Serda M; Dąbrowski JM; Arnaut LG; Szczygieł M; Urbańska K; Stochel G; Elas M
Free Radic Biol Med; 2014 Aug; 73():239-51. PubMed ID: 24835769
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence.
Zaidi SI; Oleinick NL; Zaim MT; Mukhtar H
Photochem Photobiol; 1993 Dec; 58(6):771-6. PubMed ID: 8309997
[TBL] [Abstract][Full Text] [Related]
38. Fluence rate as a modulator of PDT mechanisms.
Henderson BW; Busch TM; Snyder JW
Lasers Surg Med; 2006 Jun; 38(5):489-93. PubMed ID: 16615136
[TBL] [Abstract][Full Text] [Related]
39. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.
Ferrario A; Von Tiehl K; Wong S; Luna M; Gomer CJ
Cancer Res; 2002 Jul; 62(14):3956-61. PubMed ID: 12124326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
